These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25372511)

  • 1. Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers.
    Alam M; Kakar R; Nodzenski M; Ibrahim O; Disphanurat W; Bolotin D; Borovicka JH; Pace N; Alster TS; Arndt KA; Beer KR; Berlin JM; Bernstein LJ; Brightman LA; Butterwick K; Cox SE; Chotzen V; Fabi SG; Fitzpatrick RE; Geronemus RG; Goldman MP; Groff WF; Kaminer MS; Kilmer S; Rohrer TE; Tanzi EL; Silva SK; Yoo SS; Weinkle SH; Strasswimmer J; Poon E; Dover JS
    JAMA Dermatol; 2015 Mar; 151(3):271-7. PubMed ID: 25372511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Injectable neurotoxins and fillers: there is no free lunch.
    Emer J; Waldorf H
    Clin Dermatol; 2011; 29(6):678-90. PubMed ID: 22014990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injection technique in neurotoxins and fillers: Planning and basic technique.
    Alam M; Tung R
    J Am Acad Dermatol; 2018 Sep; 79(3):407-419. PubMed ID: 30119865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rates of Vascular Occlusion Associated With Using Needles vs Cannulas for Filler Injection.
    Alam M; Kakar R; Dover JS; Harikumar V; Kang BY; Wan HT; Poon E; Jones DH
    JAMA Dermatol; 2021 Feb; 157(2):174-180. PubMed ID: 33377939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determining the safety of office-based surgery: what 10 years of Florida data and 6 years of Alabama data reveal.
    Starling J; Thosani MK; Coldiron BM
    Dermatol Surg; 2012 Feb; 38(2):171-7. PubMed ID: 22093178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complications of injectable fillers and neurotoxins.
    Cox SE; Adigun CG
    Dermatol Ther; 2011; 24(6):524-36. PubMed ID: 22515668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection technique in neurotoxins and fillers: Indications, products, and outcomes.
    Alam M; Tung R
    J Am Acad Dermatol; 2018 Sep; 79(3):423-435. PubMed ID: 30119866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lasers, fillers, and neurotoxins: avoiding complications in the cosmetic facial practice.
    Hassouneh B; Newman JP
    Facial Plast Surg Clin North Am; 2013 Nov; 21(4):585-98. PubMed ID: 24200377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 2).
    Vanaman M; Fabi SG; Carruthers J
    Dermatol Surg; 2016 Jan; 42(1):12-20. PubMed ID: 26716710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient safety in procedural dermatology: Part II. Safety related to cosmetic procedures.
    Lolis M; Dunbar SW; Goldberg DJ; Hansen TJ; MacFarlane DF
    J Am Acad Dermatol; 2015 Jul; 73(1):15-24; quiz 25-6. PubMed ID: 26089046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications from toxins and fillers in the dermatology clinic: recognition, prevention, and treatment.
    Dayan SH
    Facial Plast Surg Clin North Am; 2013 Nov; 21(4):663-73. PubMed ID: 24200384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable and topical neurotoxins in dermatology: Indications, adverse events, and controversies.
    Giordano CN; Matarasso SL; Ozog DM
    J Am Acad Dermatol; 2017 Jun; 76(6):1027-1042. PubMed ID: 28522039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventing, identifying, and managing cosmetic procedure complications, part 1: soft-tissue augmentation and botulinum toxin injections.
    Brown M
    Cutis; 2016 Jun; 97(6):E28-9. PubMed ID: 27416095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk profiles of different injectable fillers: results from the Injectable Filler Safety Study (IFS Study).
    Zielke H; Wölber L; Wiest L; Rzany B
    Dermatol Surg; 2008 Mar; 34(3):326-35; discussion 335. PubMed ID: 18177399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of reported adverse events to injectable polylactic acid after recommending an increased dilution: 8-year results from the Injectable Filler Safety study.
    Rossner F; Rossner M; Hartmann V; Erdmann R; Wiest LG; Rzany B
    J Cosmet Dermatol; 2009 Mar; 8(1):14-8. PubMed ID: 19250160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivations for seeking minimally invasive cosmetic procedures in an academic outpatient setting.
    Sobanko JF; Taglienti AJ; Wilson AJ; Sarwer DB; Margolis DJ; Dai J; Percec I
    Aesthet Surg J; 2015 Nov; 35(8):1014-20. PubMed ID: 26038370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Who are the Pioneers? A Critical Analysis of Innovation and Expertise in Cutaneous Noninvasive and Minimally Invasive Cosmetic and Surgical Procedures.
    Bangash HK; Eisen DB; Armstrong AW; Nelson AA; Jalian HR; Alam M; Avram MM; Ibrahimi OA
    Dermatol Surg; 2016 Mar; 42(3):335-51. PubMed ID: 26918969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complications in the Cosmetic Dermatology Patient: A Review and Our Experience (Part 1).
    Vanaman M; Fabi SG; Carruthers J
    Dermatol Surg; 2016 Jan; 42(1):1-11. PubMed ID: 26716709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications following injection of soft-tissue fillers.
    Ozturk CN; Li Y; Tung R; Parker L; Piliang MP; Zins JE
    Aesthet Surg J; 2013 Aug; 33(6):862-77. PubMed ID: 23825309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lasers and losers in the eyes of the law: liability for head and neck procedures.
    Svider PF; Carron MA; Zuliani GF; Eloy JA; Setzen M; Folbe AJ
    JAMA Facial Plast Surg; 2014; 16(4):277-83. PubMed ID: 24744090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.